Boule Diagnostics AB

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0011231158
SEK
3.97
0.07 (1.79%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Stille AB
Boule Diagnostics AB
Enzymatica AB
Paxman AB
Promimic AB
Senzime AB
Mentice AB
Integrum AB
BrainCool AB
OssDsign AB
Curasight A/S

Why is Boule Diagnostics AB ?

1
Poor long term growth as Operating profit has grown by an annual rate 0.15% of over the last 5 years
2
The company has declared Negative results for the last 3 consecutive quarters
  • OPERATING CASH FLOW(Y) Lowest at SEK 0.8 MM
  • DEBT-EQUITY RATIO (HY) Highest at 121.78 %
  • INTEREST(Q) At SEK 4.4 MM has Grown at 25.71%
3
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -54.78%, its profits have fallen by -1410.4%
4
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -54.78% returns in the last 1 year, the stock has also underperformed OMX Stockholm 30 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Boule Diagnostics AB for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Boule Diagnostics AB
-54.78%
-0.82
59.87%
OMX Stockholm 30
10.97%
0.59
18.59%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
4.10%
EBIT Growth (5y)
0.15%
EBIT to Interest (avg)
-2.33
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
1.04
Sales to Capital Employed (avg)
1.18
Tax Ratio
17.46%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.64%
ROE (avg)
5.22%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.20
EV to EBIT
-1.16
EV to EBITDA
-1.24
EV to Capital Employed
1.09
EV to Sales
0.73
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-94.25%
ROE (Latest)
-172.02%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

14What is working for the Company
PRE-TAX PROFIT(Q)

At SEK 8.3 MM has Grown at 109.88%

NET PROFIT(Q)

At SEK 2.14 MM has Grown at 103.14%

RAW MATERIAL COST(Y)

Fallen by -7.92% (YoY

-9What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at SEK 0.8 MM

DEBT-EQUITY RATIO (HY)

Highest at 121.78 %

INTEREST(Q)

At SEK 4.4 MM has Grown at 25.71%

Here's what is working for Boule Diagnostics AB

Pre-Tax Profit
At SEK 8.3 MM has Grown at 109.88%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (SEK MM)

Net Profit
At SEK 2.14 MM has Grown at 103.14%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (SEK MM)

Raw Material Cost
Fallen by -7.92% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Boule Diagnostics AB

Operating Cash Flow
Lowest at SEK 0.8 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (SEK MM)

Interest
At SEK 4.4 MM has Grown at 25.71%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (SEK MM)

Debt-Equity Ratio
Highest at 121.78 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio